Champions Oncology Inc reports results for the quarter ended October 31 - Earnings Summary

Champions Oncology

11/12/2024 21:31

* Champions Oncology Inc  CSBR.OQ  reported quarterly
adjusted
earnings of 5 cents​​ per share for the quarter ended October
31, higher than the same quarter last year, when the company
reported EPS of -15 cents.  The lone analyst forecast for the
quarter was for earnings of one cent per share. 
    * Revenue rose 16.6% to $13.49 million from a year ago;
analysts
expected $13.05 million. 
    * The company reported quarterly net income of $728
thousand.
    * Champions Oncology Inc shares had risen by 7.0% this
quarter and
lost 7.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 133.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Champions
Oncology Inc is $6.00 
This summary was machine generated from LSEG data December 11 at
09:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Oct. 31 2024      0.01           0.05           Beat
 Jul. 31 2024      -0.03          0.11           Beat
 Apr. 30 2024      -0.16          0.01           Beat
 Jan. 31 2024      -0.06          -0.16          Missed